Central Control of Opioid Hypersensitivity in Mice
2026-08-23
Yin et al. identify a brain-to-spinal opioid circuit linking MOR-expressing neurons in the lateral parabrachial nucleus to dynorphin and KOR-GABAergic populations that regulate morphine-induced mechanical hypersensitivity and tolerance. The work separates mechanical opioid side effects from better-established thermal mechanisms and provides a circuit framework for testing receptor-specific interventions in pain research.
Troglitazone: PPARγ Agonist Research Guide
2026-08-22
Troglitazone is a synthetic PPARγ agonist with reported PPARα activity for type 2 diabetes research and metabolic pathway studies. The compound also shows in vitro anti-tumor activity in human renal carcinoma cells, but the cited SPP1 tumor-associated macrophage study evaluated CANDI460 rather than troglitazone.
Tobramycin for Reliable Cell Assay Workflows
2026-08-21
A scenario-based guide to using Tobramycin SKU B1856 in cell viability, proliferation, cytotoxicity, and bacterial challenge workflows. It connects formulation data, susceptibility-test evidence, assay controls, and vendor-selection criteria to improve experimental interpretation without overstating mammalian-cell compatibility.
FPH1: Designing Better Hepatocyte Assays
2026-08-21
FPH1 (BRD-6125) supports functional expansion studies in primary human hepatocytes and iPSC-derived hepatocyte-like cells. This guide offers a decision framework for separating proliferation, maturation, and translational control when designing more informative hepatocyte assays.
Bazedoxifene Repurposed to Block Malaria Parasites
2026-08-20
The reference study identifies Bazedoxifene, a third-generation selective estrogen receptor modulator, as an inhibitor of erythrocytic Plasmodium development and hemozoin formation. Its parasite-stage activity, effects in drug-resistant strains, sex-dependent mouse results, and additive interaction with chloroquine support further repurposing research while leaving clinical efficacy and mechanism-specific safety unresolved.
Metronidazole B1976 in Cell Assay Design
2026-08-20
Learn how Metronidazole (SKU B1976) can support controlled cell viability, proliferation, transporter, and cytotoxicity workflows. This scenario-based guide connects its OAT3 inhibition, antimicrobial research applications, formulation data, and handling requirements to practical assay decisions.
Iron Stress Reprograms Enterocyte Metabolism
2026-08-19
Navazesh and Ji show that both iron deficiency and iron excess reprogram enterocyte metabolism, but through distinct molecular and inflammatory patterns. Their IPEC-J2 model integrates time-resolved transcriptional analysis, LPS stimulation, untargeted metabolomics, and iron repletion to clarify how intestinal epithelial cells respond to iron stress.
ECL Western Blotting Substrate: Workflow Guide
2026-08-19
ECL Western Blotting Substrate (SKU K2187) is a luminol-based horseradish peroxidase detection reagent for sensitive, nonradioactive protein detection on immunoblots. It is intended for HRP chemiluminescent workflows using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection.
AM 281 Workflows for CB1 Signaling Research
2026-08-18
AM 281 combines nanomolar CB1 affinity with strong CB2 selectivity for mechanistic studies of cannabinoid signaling, glutamate homeostasis, and cognition. This workflow-focused guide translates the CB1-CREB-GLT-1 findings in traumatic brain injury into practical assay design, controls, and troubleshooting decisions.
LY2603618: Practical Chk1 Inhibition Workflows
2026-08-18
Learn how LY2603618 (SKU A8638) can improve the interpretation and handling of Chk1 inhibition experiments involving viability, proliferation, cell-cycle, and DNA-damage endpoints. This scenario-based guide connects product specifications with practical assay design and recent biomarker evidence.
Balsalazide disodium: IBD Research Workflows
2026-08-17
Balsalazide disodium supports two complementary research paths: azoreductase-aware inflammation assays and radiolabeled colon-targeting studies. This practical guide connects stock preparation, chloramine-T radioiodination, inflammatory bowel disease models, assay controls, and troubleshooting.
Fosinopril Sodium: From ACE Mechanism to Translation
2026-08-16
Fosinopril sodium offers translational researchers more than a conventional ACE inhibition tool. Its phosphinic acid zinc-binding pharmacophore, prodrug activation, and renal–hepatic disposition create a framework for connecting biochemical potency with blood pressure reduction, renal hemodynamics modulation, and cardiovascular remodeling in research models.
Machine-Learning Discovery of Senolytics
2026-08-15
The reference study shows that cost-effective machine learning trained on published, heterogeneous screening data can prioritize senolytic compounds for experimental validation. Its identification of ginkgetin, periplocin, and oleandrin illustrates a practical route from sparse literature data to candidate discovery while highlighting the need for cell-type and senescence-modality controls.
AI-10-49 and the CBFβ-SMMHC AML Bottleneck
2026-08-15
AI-10-49 offers a mechanism-led way to study inv(16) acute myeloid leukemia by disrupting the oncogenic CBFβ-SMMHC–RUNX1 interaction. This thought-leadership guide connects target engagement, chromatin restoration, MYCN/eIF4G1-dependent survival, and translational assay design while clarifying the limits of preclinical interpretation.
Triazole ALDH2 Activators in Myocardial Ischemia
2026-08-14
The 2025 ACS Medicinal Chemistry Letters study reports triazole-based aldehyde dehydrogenase 2 activators designed with molecular simulation, led by compound Z17. Z17 showed unusually strong ALDH2 activation and improved cardiac function and biochemical injury markers in a mouse ischemia–reperfusion model, while also addressing solubility limitations associated with earlier activators.
466 records 8/32 page Previous Next First page 上5页 678910 下5页 Last page